High-Risk Cancer Clinical Trial
Official title:
Anti-PD-1 Antibody and P-GEMOX Chemotherapy Combined With Radiotherapy in High-risk Early-Stage Extranodal NK/T Cell Lymphoma, Nasal Type: A Multi-center Phase II Study
The current study is a phase II multi-center single arm trial to evaluate the efficacy and safety of inductive Anti-PD-1+P-GEMOX treatment followed by radiotherapy and concurrent Anti-PD-1 antibody in early-stage high-risk extranodal NK/T cell lymphoma, nasal type
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT06041490 -
Adjuvant Therapy for High-risk Hepatocellular Carcinoma Post Liver Transplantation
|
Phase 2 | |
| Recruiting |
NCT03978663 -
Three Fraction Radiation to Induce Immuno-Oncologic Response
|
N/A | |
| Withdrawn |
NCT05120622 -
Trial of Local Cystoscopic Injection of Tremelimumab Plus Systemic Durvalumab for High Risk Non-Muscle Invasive Bladder Cancer
|
Phase 1/Phase 2 | |
| Recruiting |
NCT04947098 -
Prevent Cancer- Greenville
|
||
| Recruiting |
NCT06020443 -
Adherence to Lung Cancer Screening by Low-dose Thoracic CT in Haut-Rhin Department, France.
|
N/A | |
| Completed |
NCT02308280 -
Nonmyeloablative Allogeneic Stem Cell Transplant Followed by Bortezomib in High-risk Multiple Myeloma Patients
|
Phase 2 | |
| Active, not recruiting |
NCT06046625 -
Needs and Preferences of Patients With Head-neck Cutaneous SCC
|
||
| Recruiting |
NCT06277050 -
Maintenance Therapy With Toripalimab and Capecitabine Versus Capecitabine Alone in High-risk Nasopharyngeal Carcinoma
|
Phase 3 | |
| Completed |
NCT03343249 -
Adjunctive Smart Phone Based Smoking Cessation Treatment
|
N/A | |
| Recruiting |
NCT06327568 -
Anal Cancer and/or Precancer Screening: Performance Analysis of the BD Onclarity™ HPV Assay on Anal Specimens
|
||
| Terminated |
NCT01941550 -
Neoadjuvant Chemotherapy With Cabazitaxel
|
Phase 2 | |
| Recruiting |
NCT04334993 -
Pediatric-type Therapy With Pre-transplant Blinatumomab for HR Patients - Phase II Study
|
Phase 2 | |
| Recruiting |
NCT05482880 -
Decisional Conflicts, Health-related QoL and Satisfaction With Care in High-risk cSCC in the Head-neck Region
|
||
| Recruiting |
NCT05498272 -
Study of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With BRCA1/2 Gene Alterations
|
Phase 2 | |
| Terminated |
NCT01479192 -
Fenretinide in Healthy Young Women at Genetic and Familial Risk
|
Phase 3 | |
| Recruiting |
NCT05557487 -
Taiwan Real-world LDCT Screening Behavior and Outcome Research for High Risk Subjects Based on Health Promotion Administration
|
||
| Recruiting |
NCT04217356 -
Study of Stem Cell Transplant vs. Non-Transplant Therapies in High-Risk Myelofibrosis
|
||
| Recruiting |
NCT04740866 -
Adjuvant Radiotherapy Versus Observation After Radical Cystectomy in High Risk Urothelial Bladder Cancer
|
N/A | |
| Recruiting |
NCT04905329 -
A Multicenter Prospective Post-registration Study of Empegfilgrastim to Evaluate Safety and Efficacy in Special Cancer Populations
|
||
| Active, not recruiting |
NCT01827137 -
WT1 Analog Peptide Vaccine in Patients With Multiple Myeloma Following Autologous Stem Cell Transplantation
|
N/A |